A multi-omics approach to reveal the key evidence of GDF10 as a novel therapeutic biomarker for breast cancer

A multi-omics approach to reveal the key evidence of GDF10 as a novel therapeutic biomarker for breast cancer

Breast cancer (BC) is the most common type of invasive cancer diagnosed in women. It is the second leading cause of death from cancer and the utmost important medical concern women face today. Growth differentiation factor 10 (GDF10) is a member of the transforming growth factor β (TGF-β) superfamil...

Full description

Bibliographic Details
Main Authors: Ferdausur Rahman, Tousif Bin Mahmood, Al Amin, Rahat Alam, Jannatul Ferdous Jharna, Abdus Samad, Foysal Ahammad
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Informatics in Medicine Unlocked
Subjects:
GDF10
Breast cancer
Therapeutic target
Mutation in GDF10
Prognostic rate
Online Access:http://www.sciencedirect.com/science/article/pii/S2352914820306134

Internet

http://www.sciencedirect.com/science/article/pii/S2352914820306134

Similar Items